GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Piotroski F-Score

Fresenius Medical Care AG (Fresenius Medical Care AG) Piotroski F-Score

: 7 (As of Today)
View and export this data going back to 1996. Start your Free Trial

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Fresenius Medical Care AG's Piotroski F-Score or its related term are showing as below:

FMS' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of Fresenius Medical Care AG was 7. The lowest was 4. And the median was 6.


Fresenius Medical Care AG Piotroski F-Score Historical Data

The historical data trend for Fresenius Medical Care AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 7.00 4.00 6.00 7.00

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 7.00 7.00

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Piotroski F-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 92.465 + 152.068 + 90.022 + 204.935 = $539 Mil.
Cash Flow from Operations was 152.928 + 1091.164 + 810.839 + 784.15 = $2,839 Mil.
Revenue was 5036.636 + 5227.818 + 5268.129 + 5439.352 = $20,972 Mil.
Gross Profit was 1230.345 + 1297.087 + 1311.63 + 1471.816 = $5,311 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(37875.121 + 38009.117 + 37876.639 + 38030.625 + 37000.881) / 5 = $37758.4766 Mil.
Total Assets at the begining of this year (Dec22) was $37,875 Mil.
Long-Term Debt & Capital Lease Obligation was $11,438 Mil.
Total Current Assets was $9,489 Mil.
Total Current Liabilities was $6,665 Mil.
Net Income was 173.305 + 155.539 + 227.822 + 147.038 = $704 Mil.

Revenue was 5009.217 + 5028.203 + 5045.709 + 5293.222 = $20,376 Mil.
Gross Profit was 1292.791 + 1316.664 + 1231.185 + 1303.786 = $5,144 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(38832.269 + 38242.43 + 38128.674 + 38026.173 + 37875.121) / 5 = $38220.9334 Mil.
Total Assets at the begining of last year (Dec21) was $38,832 Mil.
Long-Term Debt & Capital Lease Obligation was $11,839 Mil.
Total Current Assets was $8,690 Mil.
Total Current Liabilities was $6,851 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Net Income (TTM) was 539. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 2,839. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=539.49/37875.121
=0.01424391

ROA (Last Year)=Net Income/Total Assets (Dec21)
=703.704/38832.269
=0.01812163

Fresenius Medical Care AG's return on assets of this year was 0.01424391. Fresenius Medical Care AG's return on assets of last year was 0.01812163. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Fresenius Medical Care AG's current Net Income (TTM) was 539. Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 2,839. ==> 2,839 > 539 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=11438.222/37758.4766
=0.30293124

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=11838.636/38220.9334
=0.3097422

Fresenius Medical Care AG's gearing of this year was 0.30293124. Fresenius Medical Care AG's gearing of last year was 0.3097422. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=9488.998/6664.766
=1.42375561

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=8690.101/6850.968
=1.26844863

Fresenius Medical Care AG's current ratio of this year was 1.42375561. Fresenius Medical Care AG's current ratio of last year was 1.26844863. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Fresenius Medical Care AG's number of shares in issue this year was 586.827. Fresenius Medical Care AG's number of shares in issue last year was 586.831. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5310.878/20971.935
=0.25323739

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5144.426/20376.351
=0.25247043

Fresenius Medical Care AG's gross margin of this year was 0.25323739. Fresenius Medical Care AG's gross margin of last year was 0.25247043. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=20971.935/37875.121
=0.55371269

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=20376.351/38832.269
=0.52472728

Fresenius Medical Care AG's asset turnover of this year was 0.55371269. Fresenius Medical Care AG's asset turnover of last year was 0.52472728. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Fresenius Medical Care AG  (NYSE:FMS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Fresenius Medical Care AG Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors